Adjuvant therapy for high-risk stage II or stage III colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study

被引：0
|
作者：
Chen, C-H. [1 ,2 ]
Wu, S-Y. [3 ]
机构：
[1] Taipei Med Univ, Wan Fang Hosp, Dept Colorectal Surg, Taipei, Taiwan
[2] Taipei Med Univ, Municipal Wan Fang Hosp, Taipei, Taiwan
[3] Taipei Med Univ, Municipal Wan Fang Hosp, Dept Radiat Oncol, Taipei Med, Taipei, Taiwan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
91P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adjuvant Therapy for High-Risk Stage II or III Colon Adenocarcinoma: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
    Chang, Chia-Lun
    Yuan, Kevin Sheng-Po
    Wu, Alexander T. H.
    Wu, Szu-Yuan
    CANCERS, 2019, 11 (12)
  • [2] Outcomes of Adjuvant Oral versus Intravenous Fluoropyrimidines for High-Risk Stage II or Stage III Colon Adenocarcinoma: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
    Zhang, Jiaqiang
    Yen, Yu-Chun
    Qin, Lei
    Chang, Chia-Lun
    Yuan, Kevin Sheng-Po
    Wu, Alexander T. H.
    Wu, Szu-Yuan
    JOURNAL OF CANCER, 2020, 11 (14): : 4157 - 4165
  • [3] Adjuvant Chemotherapy for High-Risk Stage II Colon Cancer: A Population-Based Study
    Butare, Annmarie
    Sutton, Tia
    Kantzler, Elizabeth
    Kennedy, Katie N.
    Tumin, Dmitry
    Honaker, Michael D.
    JOURNAL OF GASTROINTESTINAL CANCER, 2025, 56 (01)
  • [4] Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan
    Wang, Liming
    Hirano, Yasumitsu
    Heng, Gregory
    Ishii, Toshimasa
    Kondo, Hiroka
    Hara, Kiyoka
    Obara, Nao
    Asari, Masahiro
    Kato, Takuya
    Yamaguchi, Shigeki
    ANTICANCER RESEARCH, 2020, 40 (03) : 1651 - 1659
  • [5] Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort study
    Garg, Mahek
    Venugopalan, Veena
    Vouri, Scott M.
    Diaby, Vakaramoko
    Iovine, Nicole M.
    Park, Haesuk
    PHARMACOTHERAPY, 2023, 43 (09): : 883 - 893
  • [6] LipoCol Forte capsules reduce the risk of liver cancer: A propensity score-matched, nationwide, population-based cohort study
    Lai, Hsiang-Chun
    Lin, Hung-Jen
    Shih, Ying-Hsiu
    Chou, Jen-Wei
    Lin, Kuan-Wen
    Jeng, Long-Bin
    Huang, Sheng-Teng
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (05) : 828 - 842
  • [7] LipoCol Forte capsules reduce the risk of liver cancer: A propensity score-matched, nationwide, population-based cohort study
    Hsiang-Chun Lai
    Hung-Jen Lin
    Ying-Hsiu Shih
    Jen-Wei Chou
    Kuan-Wen Lin
    Long-Bin Jeng
    Sheng-Teng Huang
    World Journal of Gastrointestinal Oncology, 2023, (05) : 828 - 842
  • [8] Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis
    Raoof, Mustafa
    Blakely, Andrew M.
    Melstrom, Laleh G.
    Lee, Byrne
    Warner, Susanne G.
    Chung, Vincent
    Singh, Gagandeep
    Chen, Yi-Jen
    Fong, Yuman
    CANCER MEDICINE, 2019, 8 (13): : 5881 - 5890
  • [9] Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study
    Wu, Chia-Liang
    Lei, Wei-Yi
    Wang, Jaw-Shing
    Lin, Ching-En
    Chen, Chien-Lin
    Wen, Shu-Hui
    PLOS ONE, 2020, 15 (11):
  • [10] The prognostic value of signet ring cell histology in stage I/II colon cancer—a population-based, propensity score-matched analysis
    Christoph Jakob Ackermann
    Ulrich Guller
    Wolfram Jochum
    Bruno M. Schmied
    Rene Warschkow
    International Journal of Colorectal Disease, 2018, 33 : 1183 - 1193
12345